Sudden sensorineural hearing loss: Long-term follow-up results
This study describes the long-term outcome of patients suffering from sudden sensorineural hearing loss (SSHL) after an initial combined therapy of steroids with vasodilators. Eighty cases were retrospectively reviewed to evaluate the long-term audiometric data and to statistically assess the value...
Gespeichert in:
| Veröffentlicht in: | Otolaryngology-head and neck surgery 2006-05, Vol.134 (5), p.809-815 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 815 |
|---|---|
| container_issue | 5 |
| container_start_page | 809 |
| container_title | Otolaryngology-head and neck surgery |
| container_volume | 134 |
| creator | Psifidis, Anestis D. Psillas, George K. Daniilidis, Jiannis Ch |
| description | This study describes the long-term outcome of patients suffering from sudden sensorineural hearing loss (SSHL) after an initial combined therapy of steroids with vasodilators.
Eighty cases were retrospectively reviewed to evaluate the long-term audiometric data and to statistically assess the value of specific clinical parameters. The persistent long-term otoneurologic manifestations associated with SSHL were also reported.
In the long-term period, hearing level remained stable 2 months after the onset of SSHL. Patients complained of persistent tinnitus (36%), fluctuant hearing loss (8.7%), dizziness (8.7%), and classical Ménière’s triad in 2.5% of cases. Profound and total SSHL associated with vertigo are poor prognostic indicators.
In terms of cost-effectiveness, a steroid-vasodilator therapy for SSHL for >2 months is not recommended because no additional effect was evidenced. Persistent otoneurologic manifestations, mainly tinnitus or dizziness are relatively common, particularly in patients with severe to total SSHL.
EBM rating: C-4 |
| doi_str_mv | 10.1016/j.otohns.2005.12.002 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67923105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1016_j.otohns.2005.12.002</sage_id><els_id>S0194599805022114</els_id><sourcerecordid>67923105</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5213-35ebee083f07bc22b0bdec8449a6c85526b005d2b16190a5a3eb303e5fedec3e3</originalsourceid><addsrcrecordid>eNqNkMFO3DAQhq2qiN0Cb1BVOfWWMLZjJ0FoJboqBWkFB-BsOc5kycobL3bSFW9fo6zUG3CaOfzfr5mPkO8UMgpUnm8yN7jnPmQMQGSUZQDsC5lTqIpUlrT4SuZAqzwVVVXOyLcQNgAgZVEckxmVMi8Er-Zk8TA2DfZJwD443_U4em2TZ9RxXyfWhXCRrFy_Tgf026R11rp9Ou4Sj2G0QzglR622Ac8O84Q8Xf9-XN6kq_s_t8urVWoEozzlAmtEKHkLRW0Yq6Fu0JR5XmlpSiGYrOMTDauppBVooTnWHDiKFmOOIz8hP6fenXcvI4ZBbbtg0FrdoxuDkkXFOAURg_kUND7e7rFVO99ttX9VFNSbN7VRkzf15k1RpqK3iP049I_1Fpv_0EFUDFxOgX1n8fVTper-5u7XNQPOeMTphAe9RrVxo--jro9uWkwMRrF_O_QqmA57g03n0Qyqcd37Bf8A8d2kDw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67923105</pqid></control><display><type>article</type><title>Sudden sensorineural hearing loss: Long-term follow-up results</title><source>SAGE Complete A-Z List</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Psifidis, Anestis D. ; Psillas, George K. ; Daniilidis, Jiannis Ch</creator><creatorcontrib>Psifidis, Anestis D. ; Psillas, George K. ; Daniilidis, Jiannis Ch</creatorcontrib><description>This study describes the long-term outcome of patients suffering from sudden sensorineural hearing loss (SSHL) after an initial combined therapy of steroids with vasodilators.
Eighty cases were retrospectively reviewed to evaluate the long-term audiometric data and to statistically assess the value of specific clinical parameters. The persistent long-term otoneurologic manifestations associated with SSHL were also reported.
In the long-term period, hearing level remained stable 2 months after the onset of SSHL. Patients complained of persistent tinnitus (36%), fluctuant hearing loss (8.7%), dizziness (8.7%), and classical Ménière’s triad in 2.5% of cases. Profound and total SSHL associated with vertigo are poor prognostic indicators.
In terms of cost-effectiveness, a steroid-vasodilator therapy for SSHL for >2 months is not recommended because no additional effect was evidenced. Persistent otoneurologic manifestations, mainly tinnitus or dizziness are relatively common, particularly in patients with severe to total SSHL.
EBM rating: C-4</description><identifier>ISSN: 0194-5998</identifier><identifier>EISSN: 1097-6817</identifier><identifier>DOI: 10.1016/j.otohns.2005.12.002</identifier><identifier>PMID: 16647539</identifier><language>eng</language><publisher>Los Angeles, CA: Mosby, Inc</publisher><subject>Adolescent ; Adult ; Aged ; Audiometry ; Child ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Glucocorticoids - therapeutic use ; Hearing Loss, Sensorineural - drug therapy ; Hearing Loss, Sensorineural - physiopathology ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Time Factors ; Treatment Outcome ; Vasodilator Agents - therapeutic use</subject><ispartof>Otolaryngology-head and neck surgery, 2006-05, Vol.134 (5), p.809-815</ispartof><rights>2006 American Academy of Otolaryngology–Head and Neck Surgery Foundation</rights><rights>2006 SAGE Publications</rights><rights>2006 American Association of Otolaryngology‐Head and Neck Surgery Foundation (AAO‐HNSF)</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5213-35ebee083f07bc22b0bdec8449a6c85526b005d2b16190a5a3eb303e5fedec3e3</citedby><cites>FETCH-LOGICAL-c5213-35ebee083f07bc22b0bdec8449a6c85526b005d2b16190a5a3eb303e5fedec3e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1016/j.otohns.2005.12.002$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1016/j.otohns.2005.12.002$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,1411,21798,27901,27902,43597,43598,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16647539$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Psifidis, Anestis D.</creatorcontrib><creatorcontrib>Psillas, George K.</creatorcontrib><creatorcontrib>Daniilidis, Jiannis Ch</creatorcontrib><title>Sudden sensorineural hearing loss: Long-term follow-up results</title><title>Otolaryngology-head and neck surgery</title><addtitle>Otolaryngol Head Neck Surg</addtitle><description>This study describes the long-term outcome of patients suffering from sudden sensorineural hearing loss (SSHL) after an initial combined therapy of steroids with vasodilators.
Eighty cases were retrospectively reviewed to evaluate the long-term audiometric data and to statistically assess the value of specific clinical parameters. The persistent long-term otoneurologic manifestations associated with SSHL were also reported.
In the long-term period, hearing level remained stable 2 months after the onset of SSHL. Patients complained of persistent tinnitus (36%), fluctuant hearing loss (8.7%), dizziness (8.7%), and classical Ménière’s triad in 2.5% of cases. Profound and total SSHL associated with vertigo are poor prognostic indicators.
In terms of cost-effectiveness, a steroid-vasodilator therapy for SSHL for >2 months is not recommended because no additional effect was evidenced. Persistent otoneurologic manifestations, mainly tinnitus or dizziness are relatively common, particularly in patients with severe to total SSHL.
EBM rating: C-4</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Audiometry</subject><subject>Child</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Hearing Loss, Sensorineural - drug therapy</subject><subject>Hearing Loss, Sensorineural - physiopathology</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Vasodilator Agents - therapeutic use</subject><issn>0194-5998</issn><issn>1097-6817</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMFO3DAQhq2qiN0Cb1BVOfWWMLZjJ0FoJboqBWkFB-BsOc5kycobL3bSFW9fo6zUG3CaOfzfr5mPkO8UMgpUnm8yN7jnPmQMQGSUZQDsC5lTqIpUlrT4SuZAqzwVVVXOyLcQNgAgZVEckxmVMi8Er-Zk8TA2DfZJwD443_U4em2TZ9RxXyfWhXCRrFy_Tgf026R11rp9Ou4Sj2G0QzglR622Ac8O84Q8Xf9-XN6kq_s_t8urVWoEozzlAmtEKHkLRW0Yq6Fu0JR5XmlpSiGYrOMTDauppBVooTnWHDiKFmOOIz8hP6fenXcvI4ZBbbtg0FrdoxuDkkXFOAURg_kUND7e7rFVO99ttX9VFNSbN7VRkzf15k1RpqK3iP049I_1Fpv_0EFUDFxOgX1n8fVTper-5u7XNQPOeMTphAe9RrVxo--jro9uWkwMRrF_O_QqmA57g03n0Qyqcd37Bf8A8d2kDw</recordid><startdate>200605</startdate><enddate>200605</enddate><creator>Psifidis, Anestis D.</creator><creator>Psillas, George K.</creator><creator>Daniilidis, Jiannis Ch</creator><general>Mosby, Inc</general><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>8BM</scope></search><sort><creationdate>200605</creationdate><title>Sudden sensorineural hearing loss: Long-term follow-up results</title><author>Psifidis, Anestis D. ; Psillas, George K. ; Daniilidis, Jiannis Ch</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5213-35ebee083f07bc22b0bdec8449a6c85526b005d2b16190a5a3eb303e5fedec3e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Audiometry</topic><topic>Child</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Hearing Loss, Sensorineural - drug therapy</topic><topic>Hearing Loss, Sensorineural - physiopathology</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Vasodilator Agents - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Psifidis, Anestis D.</creatorcontrib><creatorcontrib>Psillas, George K.</creatorcontrib><creatorcontrib>Daniilidis, Jiannis Ch</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>ComDisDome</collection><jtitle>Otolaryngology-head and neck surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Psifidis, Anestis D.</au><au>Psillas, George K.</au><au>Daniilidis, Jiannis Ch</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sudden sensorineural hearing loss: Long-term follow-up results</atitle><jtitle>Otolaryngology-head and neck surgery</jtitle><addtitle>Otolaryngol Head Neck Surg</addtitle><date>2006-05</date><risdate>2006</risdate><volume>134</volume><issue>5</issue><spage>809</spage><epage>815</epage><pages>809-815</pages><issn>0194-5998</issn><eissn>1097-6817</eissn><abstract>This study describes the long-term outcome of patients suffering from sudden sensorineural hearing loss (SSHL) after an initial combined therapy of steroids with vasodilators.
Eighty cases were retrospectively reviewed to evaluate the long-term audiometric data and to statistically assess the value of specific clinical parameters. The persistent long-term otoneurologic manifestations associated with SSHL were also reported.
In the long-term period, hearing level remained stable 2 months after the onset of SSHL. Patients complained of persistent tinnitus (36%), fluctuant hearing loss (8.7%), dizziness (8.7%), and classical Ménière’s triad in 2.5% of cases. Profound and total SSHL associated with vertigo are poor prognostic indicators.
In terms of cost-effectiveness, a steroid-vasodilator therapy for SSHL for >2 months is not recommended because no additional effect was evidenced. Persistent otoneurologic manifestations, mainly tinnitus or dizziness are relatively common, particularly in patients with severe to total SSHL.
EBM rating: C-4</abstract><cop>Los Angeles, CA</cop><pub>Mosby, Inc</pub><pmid>16647539</pmid><doi>10.1016/j.otohns.2005.12.002</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0194-5998 |
| ispartof | Otolaryngology-head and neck surgery, 2006-05, Vol.134 (5), p.809-815 |
| issn | 0194-5998 1097-6817 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67923105 |
| source | SAGE Complete A-Z List; MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection |
| subjects | Adolescent Adult Aged Audiometry Child Drug Therapy, Combination Female Follow-Up Studies Glucocorticoids - therapeutic use Hearing Loss, Sensorineural - drug therapy Hearing Loss, Sensorineural - physiopathology Humans Male Middle Aged Retrospective Studies Time Factors Treatment Outcome Vasodilator Agents - therapeutic use |
| title | Sudden sensorineural hearing loss: Long-term follow-up results |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T02%3A40%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sudden%20sensorineural%20hearing%20loss:%20Long-term%20follow-up%20results&rft.jtitle=Otolaryngology-head%20and%20neck%20surgery&rft.au=Psifidis,%20Anestis%20D.&rft.date=2006-05&rft.volume=134&rft.issue=5&rft.spage=809&rft.epage=815&rft.pages=809-815&rft.issn=0194-5998&rft.eissn=1097-6817&rft_id=info:doi/10.1016/j.otohns.2005.12.002&rft_dat=%3Cproquest_cross%3E67923105%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67923105&rft_id=info:pmid/16647539&rft_sage_id=10.1016_j.otohns.2005.12.002&rft_els_id=S0194599805022114&rfr_iscdi=true |